Literature DB >> 32610056

Cytotoxicity of juglone and thymoquinone against pancreatic cancer cells.

Namrata Karki1, Sita Aggarwal2, Roger A Laine3, Frank Greenway2, Jack N Losso4.   

Abstract

Juglone and thymoquinone are cytotoxic to pancreatic cancer cells. The aim of this study was to investigate, using an analysis of isobolograms, the type and degree of interactions between juglone and thymoquinone on MIA PaCa-2 pancreatic cancer cells. Cell viability was evaluated using the MTT assay. Cell death was determined by flow cytometry. The IC50 value for juglone and TQ in combination was found to be 24.75 μM, which was higher than juglone or TQ alone. Juglone alone killed Mia Paca-2 cells by ferroptosis. At concentrations where 10, 20 or 50% of cells were affected, there existed a moderate antagonistic relationship between juglone and TQ as indicated by the combination index (CI) value determined by the Compusyn software. At concentrations that affected 75% and 90% of cells, there were nearly an additive effect with CI value of 1.09249 and 0.92391, respectively. Moderate synergism was only seen at concentration where 95% of cells were affected, and the corresponding concentration of juglone and TQ at that combination was 40.90 μM and 511.19 μM, respectively.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Combinatorial index; Isobologram; Juglone; Pancreatic cancer; Thymoquinone

Mesh:

Substances:

Year:  2020        PMID: 32610056      PMCID: PMC9115841          DOI: 10.1016/j.cbi.2020.109142

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.168


  51 in total

1.  Anticancer activity and mechanism of juglone on human cervical carcinoma HeLa cells.

Authors:  Wei Zhang; Anheng Liu; Yan Li; Xingyu Zhao; Shijie Lv; Wenhe Zhu; Ying Jin
Journal:  Can J Physiol Pharmacol       Date:  2012-11-18       Impact factor: 2.273

2.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Authors:  H A Burris; M J Moore; J Andersen; M R Green; M L Rothenberg; M R Modiano; M C Cripps; R K Portenoy; A M Storniolo; P Tarassoff; R Nelson; F A Dorr; C D Stephens; D D Von Hoff
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

3.  Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells.

Authors:  Claudia Kürbitz; Daniel Heise; Torben Redmer; Freya Goumas; Alexander Arlt; Johannes Lemke; Gerald Rimbach; Holger Kalthoff; Anna Trauzold
Journal:  Cancer Sci       Date:  2011-02-24       Impact factor: 6.716

4.  Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.

Authors:  Sanjeev Banerjee; Ahmed O Kaseb; Zhiwei Wang; Deujan Kong; Mussop Mohammad; Subhash Padhye; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

5.  HPLC determination of phenolic acids, flavonoids and juglone in walnut leaves.

Authors:  Violeta Nour; Ion Trandafir; Sina Cosmulescu
Journal:  J Chromatogr Sci       Date:  2012-11-06       Impact factor: 1.618

6.  Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells.

Authors:  B Kiran Aithal; M R Sunil Kumar; B Nageshwar Rao; Nayanabhirama Udupa; B S Satish Rao
Journal:  Cell Biol Int       Date:  2009-06-23       Impact factor: 3.612

7.  Investigation of apoptotic effect of juglone on CCL-228-SW 480 colon cancer cell line.

Authors:  Dilek Bayram; Meltem Özgöçmen; Ilkay Armagan; Murat Sevimli; Gülçin Yavuz Türel; Nurgül Şenol
Journal:  J Cancer Res Ther       Date:  2019 Jan-Mar       Impact factor: 1.805

8.  Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation.

Authors:  Daniel Relles; Galina I Chipitsyna; Qiaoke Gong; Charles J Yeo; Hwyda A Arafat
Journal:  Adv Prev Med       Date:  2016-12-26

Review 9.  Juglone in Oxidative Stress and Cell Signaling.

Authors:  Taseer Ahmad; Yuichiro J Suzuki
Journal:  Antioxidants (Basel)       Date:  2019-04-05

Review 10.  Chemoresistance in Pancreatic Cancer.

Authors:  Siyuan Zeng; Marina Pöttler; Bin Lan; Robert Grützmann; Christian Pilarsky; Hai Yang
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

View more
  3 in total

1.  Investigation of cellular effects of thymoquinone on glioma cell.

Authors:  Eray Metin Guler; Behice Hande Sisman; Abdurrahim Kocyigit; Mustafa Aziz Hatiboglu
Journal:  Toxicol Rep       Date:  2021-01-04

Review 2.  Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis.

Authors:  Ravi Raj Pal; Vasundhara Rajpal; Priya Singh; Shubhini A Saraf
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

3.  Targeting Cancer Metabolism Plasticity with JX06 Nanoparticles via Inhibiting PDK1 Combined with Metformin for Endometrial Cancer Patients with Diabetes.

Authors:  Xiao Yang; Yuan Cheng; Jingyi Zhou; Lingpu Zhang; Xingchen Li; Zhiqi Wang; Shenyi Yin; LiRong Zhai; Ting Huang; Xiaotong Wu; Boqiang Shen; Yangyang Dong; Lijun Zhao; Yujing Chi; Yuanyuan Jia; Jiaqi Wang; Yijiao He; Xiying Dong; Haihua Xiao; Jianliu Wang
Journal:  Adv Sci (Weinh)       Date:  2022-01-22       Impact factor: 16.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.